Edition:
United Kingdom

ICAD Inc (ICAD.OQ)

ICAD.OQ on NASDAQ Stock Exchange Capital Market

3.76USD
13 Dec 2017
Change (% chg)

$-0.12 (-3.09%)
Prev Close
$3.88
Open
$3.89
Day's High
$3.90
Day's Low
$3.65
Volume
7,765
Avg. Vol
7,513
52-wk High
$6.01
52-wk Low
$3.12

Select another date:

Wed, Nov 8 2017

BRIEF-ICAD reports Q3 GAAP loss per share $0.42

* Q3 revenue rose 17 percent to $7.0 million Source text for Eikon: Further company coverage:

BRIEF-ICAD Inc ‍announces approval of Xoft Axxent balloon applicators by China FDA

* ICAD Inc - ‍announces approval of Xoft Axxent balloon applicators by China Food & Drug Administration for treatment of early-stage breast cancer​ Source text for Eikon: Further company coverage:

BRIEF-ICAD reports Q2 loss per share $0.16

* iCAD reports second quarter 2017 financial results and announces $13 million credit facility with silicon valley bank

BRIEF-iCAD provides positive eBx system data in skin cancer patients

* Icad announces positive study results comparing use of company’s xoft® axxent® electronic brachytherapy (ebx®) system® to mohs surgery in treatment of early-stage non-melanoma skin cancer Source text for Eikon: Further company coverage:

Select another date: